| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_610a491d3badd24d1ea60fda8d02b7e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51 |
| filingDate |
2020-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad2bcd3a9ea51c9a7d9969cd12025e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99ead9751ebd92b6b9b3df4fc4d72def
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab24c5383536d8f734fb9d91342f715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e07ec3557beeca4622933288e4d4424c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee2b225d11831b3ac6f90a3ac0975fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd026b6cbb080aff48fd6bc8997bfe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d666d28af5850cbff745dee95c1d8737 |
| publicationDate |
2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111424046-A |
| titleOfInvention |
Hepatitis B virus X gene and application thereof |
| abstract |
The invention discloses a hepatitis B virus X gene and application thereof, which comprises an X gene sequence XXDFY. The X gene sequence XXDFY can judge the prognosis and liver regeneration condition of a patient with advanced liver cancer after hepatectomy before an operation. The tumor-free survival rate and the overall survival rate of the liver cancer patients carrying the XXDFY subtype in peripheral blood after partial hepatectomy treatment are definitely higher than those of the liver cancer patients not carrying the XXDFY subtype. |
| priorityDate |
2020-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |